BioGaia

BioGaia is a Swedish probiotic pioneer that's been running trials on a single strain for decades, rather than chasing every new microbiome trend — a research-first approach that's rare in a category full of unproven blends. We're featuring it here instead of Align, whose maker settled a $30M lawsuit over unsubstantiated "clinically proven" claims.

The core strain is Limosilactobacillus reuteri DSM 17938, sometimes paired with ATCC PTA 6475 in combo products like Gastrus. It's backed by 266 clinical studies across 22,634 individuals (BioGaia clinical studies compendium), and every strain carries Qualified Presumption of Safety (QPS) status (BioGaia Sustainability Report 2021).

Products are manufactured in Sweden under strict regulatory standards, with every batch tested for total viable count and confirmed at end of shelf life (BioGaia manufacturing, BioGaia Centre of Excellence). Gastrus PURE ACTION is certified by the Canadian Digestive Health Foundation for IBS symptom relief (CDHF).

An independent audit found GMP certification but no NSF/USP/Informed Sport mark (SupplementChecker), and EFSA rejected a narrow proposed gum-health claim in 2020 — a specific claim rejection, not a safety issue (PMC). No recalls or lawsuits found. Compared to Align, BioGaia has the clinical evidence Align's marketing claimed but couldn't fully back up.